Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea

9Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Intermittent preventive treatment of infants (IPTi) reduces early childhood malaria-related morbidity. While genotypic drug resistance markers have proven useful in predicting the efficacy of antimalarial drugs in case management, there are few equivalent data relating to their protective efficacy when used as IPTi. The present data from an IPTi trial in Papua New Guinea demonstrate how these markers can predict protective efficacy of IPTi for both Plasmodium falciparum and Plasmodium vivax.

Cite

CITATION STYLE

APA

Barnadas, C., Senn, N., Iga, J., Timinao, L., Javati, S., Malau, E., … Mueller, I. (2014). Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea. Antimicrobial Agents and Chemotherapy, 58(11), 6958–6961. https://doi.org/10.1128/AAC.03323-14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free